HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): David A. Bull James C. Stringham Shreekanth V. Karwande Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bull, D. A. Articles by Karwande, S. V. Search for Related Content PubMed PubMed Citation Articles by Bull, D. A. Articles by Karwande, S. V.

J Thorac Cardiovasc Surg 2000;119:242-250
© 2000 Mosby, Inc.

CARDIOPULMONARY SUPPORT AND PHYSIOLOGY

APROTININ PRESERVES MYOCARDIAL BIOCHEMICAL FUNCTION DURING COLD STORAGE THROUGH SUPPRESSION OF TUMOR NECROSIS FACTOR

From the Division of Cardiothoracic Surgery, Department of Surgery, University of Utah Health Sciences Center, Salt Lake City, Utah.

Address for reprints: David A. Bull, MD, Division of Cardiothoracic Surgery, Department of Surgery, University of Utah, 50 N Medical Dr, Salt Lake City, UT 84132 (E-mail: david.bull{at}hsc.utah.edu) .

Objective: Inflammatory cytokines, particularly tumor necrosis factor, contribute to myocardial dysfunction after ischemia-reperfusion injury. Aprotinin may improve outcomes in cardiac surgery through suppression of inflammatory mediators. We hypothesized that aprotinin may exert its beneficial effects through suppression of tumor necrosis factor .
Methods: Adult rat hearts were precision cut into slices with a thickness of 200 µm and stored in crystalloid cardioplegic solution alone or with one of the following additions: aprotinin or tumor necrosis factor , aprotinin plus tumor necrosis factor , a monoclonal antibody to tumor necrosis factor , or a polyclonal antibody to the tumor necrosis factor receptor. Myocardial biochemical function was assessed by adenosine triphosphate content and capacity for protein synthesis immediately after slicing (0 hours) and after 2, 4, and 6 hours of storage at 4°C. The content of tumor necrosis factor was measured by an enzyme-linked immunosorbent assay. Six slices were assayed at each time point for each solution. The data were analyzed by analysis of variance and are expressed as the mean ± standard deviation.
Results: When stored in cardioplegic solution containing aprotinin, the heart slices demonstrated (1) an increase in adenosine triphosphate content and protein synthesis (P < .0001), (2) a decrease in intramyocardial generation of tumor necrosis factor (P .0311), and (3) a decrease in uptake of tumor necrosis factor into the myocardium (P .002) compared with storage in cardioplegic solution alone. The presence of an antibody to tumor necrosis factor or an antibody to the tumor necrosis factor receptor in cardioplegic solution increased intramyocardial adenosine triphosphate content and protein synthesis (P < .0001).
Conclusions: Aprotinin preserves myocardial biochemical function during cold storage. This preservation of biochemical function is mediated through suppression of the release, uptake, and activity of tumor necrosis factor .

This article has been cited by other articles:

				M. D. McEvoy, S. T. Reeves, J. G. Reves, and F. G. Spinale Aprotinin in Cardiac Surgery: A Review of Conventional and Novel Mechanisms of Action Anesth. Analg., October 1, 2007; 105(4): 949 - 962. [Abstract] [Full Text] [PDF]

				A. Kher, K. K. Meldrum, K. L. Hile, M. Wang, B. M. Tsai, M. W. Turrentine, J. W. Brown, and D. R. Meldrum Aprotinin improves kidney function and decreases tubular cell apoptosis and proapoptotic signaling after renal ischemia-reperfusion J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 662 - 662. [Abstract] [Full Text] [PDF]

				D. A. Bull and J. Maurer Aprotinin and preservation of myocardial function after ischemia-reperfusion injury Ann. Thorac. Surg., February 1, 2003; 75(2): S735 - 739. [Abstract] [Full Text] [PDF]

				D. Pruefer, U. Buerke, M. Khalil, M. Dahm, H. Darius, H. Oelert, and M. Buerke Cardioprotective effects of the serine protease inhibitor aprotinin after regional ischemia and reperfusion on the beating heart J. Thorac. Cardiovasc. Surg., November 1, 2002; 124(5): 942 - 949. [Abstract] [Full Text] [PDF]